Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patients

Diabetes
O PoirierF Cambien

Abstract

Advanced glycation end-products (AGEs) may play an important role in the pathogenesis and progression of cardiovascular and renal complications of diabetes. Four putative AGE receptors (RAGEs), AGE-R1, AGE-R2, and AGE-R3 have been described. In this study, we scanned the sequence of the genes encoding these AGE receptors in 48 patients with type 1 diabetes and investigated the identified polymorphisms (n = 19) in 199 type 1 diabetic patients with nephropathy and 193 type 1 diabetic patients without nephropathy. Overall, none of the polymorphisms was strongly associated with nephropathy. The minor allele of a polymorphism located in the promoter region of the RAGE gene (C-1152A) conferred a weak protective effect (P < 0.05) and was associated with a longer duration of nephropathy-free diabetes (P = 0.08).

References

Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·A M SchmidtG Costache
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y M LiH Vlassara
Apr 16, 1998·Nature Genetics·P PajukantaL Peltonen
May 16, 1998·The Journal of Clinical Investigation·R E PratleyC Bogardus
Apr 6, 1999·Diabetes Care·L Liu, K Xiang
Feb 29, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D S RajM Levi

❮ Previous
Next ❯

Citations

Dec 18, 2001·Diabetes/metabolism Research and Reviews·B NazlielB Koçer
Feb 4, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Shi Fang YanAnn Marie Schmidt
Jun 1, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Johannes PillNorbert Gretz
Mar 13, 2008·Sleep & Breathing = Schlaf & Atmung·Ahmet UrsavasR Oktay Gozu
Jul 2, 2003·Experimental and Molecular Pathology·Alan W Stitt
Mar 22, 2002·Journal of Internal Medicine·H Vlassara, M R Palace
Dec 17, 2005·Antioxidants & Redox Signaling·Barry I HudsonAnn Marie Schmidt
Jun 17, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Itamar RazMogher Khamaisi
Dec 24, 2004·The British Journal of Ophthalmology·S McFarlaneA W Stitt
Dec 19, 2006·Coronary Artery Disease·Se-Jung YoonNamsik Chung
Jan 10, 2009·Clinical Biochemistry·Marta KalousováOndrej Viklický
Feb 12, 2004·Journal of Internal Medicine·H J Huttunen, H Rauvala
Feb 11, 2011·Diabetes/metabolism Research and Reviews·Nomy Levin-IainaItamar Raz
Mar 31, 2005·Metabolism: Clinical and Experimental·Keiji YoshiokaToshikazu Yoshikawa
Jan 15, 2014·Diabetes Research and Clinical Practice·Ashok Kumar TripathiOm Prakash Kalra
Sep 13, 2002·Expert Opinion on Investigational Drugs·Alan W StittMark E Cooper
Jun 1, 2016·Frontiers in Oncology·Ana Carolina Ferreira CardosoRoger Chammas
Jan 5, 2002·Diabetes/metabolism Research and Reviews·H Vlassara
Jan 1, 2013·Genes·Eoin BrennanFinian Martin
Aug 27, 2003·European Journal of Human Genetics : EJHG·Odette PoirierFrançois Cambien
Sep 30, 2008·Arquivos brasileiros de endocrinologia e metabologia·Júnia H P BarbosaLuci Tojal e Seara
Mar 12, 2009·Clinical Science·Anastasia Z KaleaBarry I Hudson
Feb 15, 2005·The Biochemical Journal·Conrad P HodgkinsonGraham J Sale

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.